Individual generic drug information

goserelin

Reference monograph

Part of registered formulation

GOSERELIN

Reference record: goserelin
Source: Mosby’s 2024 Nursing Drug Reference
Printed source pages: 636
Age groups indexed: 1

Individual active ingredientSource records are displayed separately

Overview

Extracted information for goserelin only.

Names and pronunciation

(goe′se-rel-lin) Zoladex

Source page 636

Functional class

Func. class.: Gonadotropin-releasing hormone, antineoplastic (hormone)

Source page 636

Chemical class

Chem. class.: Synthetic decapeptide analog of LHRH

Source page 636

Uses

USES: Advanced and locally confined prostate cancer stage B2-C (10.8 mg), endometriosis, advanced breast cancer, endometrial thinning (3.6 mg)

Source page 636

Dose and formulations

Extracted information for goserelin only.

Dosage and routes

DOSAGE AND ROUTES Breast cancer • Adult: SUBCUT 3.6 mg q28days or 10.8 mg q12wk into anterior abdominal wall below the navel Endometrial thinning • Adult: SUBCUT 3.6 mg 1-2 depots, 4 wk apart into anterior abdominal wall below the navel Endometriosis Adult: SUBCUT 3.6 mg q28days into an- terior abdominal wall below the navel, max 6 mo Advanced Prostate Cancer Adult: SUBCUT 3.6 mg q28days or 10.8 mg q12wk into anterior abdominal wall below the navel B2-C Prostate Cancer Adult: SUBCUT 3.6 mg into anterior ab- dominal wall below navel 8 wk before radiotherapy, then after 28 days 10.8 mg or 3.6 mg 2 doses before and 2 doses q28days after radiotherapy Available forms: Depot inj 3.6, 10.8 mg

Source page 636

Dose text by age group

Filter the extracted dose blocks for this individual drug.

Adults

Breast cancer

• Adult: SUBCUT 3.6 mg q28days or 10.8 mg q12wk into anterior abdominal wall below the navel Endometrial thinning

Candidate age grouping · source page 636

Adults

Breast cancer

• Adult: SUBCUT 3.6 mg 1-2 depots, 4 wk apart into anterior abdominal wall below the navel Endometriosis Adult: SUBCUT 3.6 mg q28days into an- terior abdominal wall below the navel, max 6 mo Advanced Prostate Cancer Adult: SUBCUT 3.6 mg q28days or 10.8 mg q12wk into anterior abdominal wall below the navel B2-C Prostate Cancer Adult: SUBCUT 3.6 mg into anterior ab- dominal wall below navel 8 wk before radiotherapy, then after 28 days 10.8 mg or 3.6 mg 2 doses before and 2 doses q28days after radiotherapy Available forms: Depot inj 3.6, 10.8 mg

Candidate age grouping · source page 636

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.

Individual generic drug information

goserelin

Reference monograph

Part of registered formulation

GOSERELIN

Reference record: goserelin
Source: Mosby’s 2024 Nursing Drug Reference
Printed source pages: 636
Age groups indexed: 1

Individual active ingredientSource records are displayed separately

Overview

Extracted information for goserelin only.

Names and pronunciation

(goe′se-rel-lin) Zoladex

Source page 636

Functional class

Func. class.: Gonadotropin-releasing hormone, antineoplastic (hormone)

Source page 636

Chemical class

Chem. class.: Synthetic decapeptide analog of LHRH

Source page 636

Uses

USES: Advanced and locally confined prostate cancer stage B2-C (10.8 mg), endometriosis, advanced breast cancer, endometrial thinning (3.6 mg)

Source page 636

Dose and formulations

Extracted information for goserelin only.

Dosage and routes

Source page 636

Dose text by age group

Filter the extracted dose blocks for this individual drug.

Adults

Breast cancer

• Adult: SUBCUT 3.6 mg q28days or 10.8 mg q12wk into anterior abdominal wall below the navel Endometrial thinning

Candidate age grouping · source page 636

Adults

Breast cancer

Candidate age grouping · source page 636

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.